167 related articles for article (PubMed ID: 1995901)
1. Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
Minakawa N; Takeda T; Sasaki T; Matsuda A; Ueda T
J Med Chem; 1991 Feb; 34(2):778-86. PubMed ID: 1995901
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of 5-thiobredinin and certain related 5-substituted imidazole-4-carboxamide ribonucleosides.
Wood SG; Upadhya KG; Dalley NK; McKernan PA; Canonico PG; Robins RK; Revankar GR
J Med Chem; 1985 Sep; 28(9):1198-203. PubMed ID: 2993613
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
Minakawa N; Matsuda A
Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles.
Srivastava PC; Streeter DG; Matthews TR; Allen LB; Sidwell RW
J Med Chem; 1976 Aug; 19(8):1020-6. PubMed ID: 184281
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of certain nucleoside and nucleotide derivatives of pyrazofurin.
Petrie CR; Revankar GR; Dalley NK; George RD; McKernan PA; Hamill RL; Robins RK
J Med Chem; 1986 Feb; 29(2):268-78. PubMed ID: 3950908
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of 2-beta-D-ribofuranosylselenazole-4- carboxamide and related derivatives.
Srivastava PC; Robins RK
J Med Chem; 1983 Mar; 26(3):445-8. PubMed ID: 6827564
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
Srivastava PC; Revankar GR; Robins RK
J Med Chem; 1984 Mar; 27(3):266-9. PubMed ID: 6699872
[TBL] [Abstract][Full Text] [Related]
8. The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides.
Matsuda A; Minakawa N; Sasaki T; Ueda T
Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2730-3. PubMed ID: 3272143
[No Abstract] [Full Text] [Related]
9. Improved synthesis and antitumor activity of 1-deazaadenosine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Bordoni T; Geroni C
J Med Chem; 1987 Sep; 30(9):1686-8. PubMed ID: 3625714
[TBL] [Abstract][Full Text] [Related]
10. 5-Amino-4-(diazoacetyl)-1-beta-D-ribofuranosylimidazole, a new antileukemic agent.
Thomas HJ; Avery LN; Brockman RW; Montgomery JA
J Med Chem; 1987 Feb; 30(2):431-4. PubMed ID: 3027342
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral/antitumor activities of certain pyrazolo[3,4-d]pyrimidine-4(5H)-selone nucleosides and related compounds.
Ugarkar BG; Cottam HB; McKernan PA; Robins RK; Revankar GR
J Med Chem; 1984 Aug; 27(8):1026-30. PubMed ID: 6086922
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides.
Revankar GR; Gupta PK; Adams AD; Dalley NK; McKernan PA; Cook PD; Canonico PG; Robins RK
J Med Chem; 1984 Nov; 27(11):1389-96. PubMed ID: 6092634
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolopyrimidine nucleosides. 18. Synthesis and chemotherapeutic activity of 4-amino-7-(3-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (3'-deoxysangivamycin) and 4-amino-7-(2-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (2'-deoxysangivamycin).
Maruyama T; Wotring LL; Townsend LB
J Med Chem; 1983 Jan; 26(1):25-9. PubMed ID: 6827526
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of 6-azacadeguomycin and certain 3,4,6-trisubstituted pyrazolo[3,4-d]pyrimidine ribonucleosides.
Petrie CR; Cottam HB; McKernan PA; Robins RK; Revankar GR
J Med Chem; 1985 Aug; 28(8):1010-6. PubMed ID: 4020823
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vivo antitumor activity of 2-amino-9H-purine-6-sulfenamide, -sulfinamide, and -sulfonamide and related purine ribonucleosides.
Revankar GR; Hanna NB; Imamura N; Lewis AF; Larson SB; Finch RA; Avery TL; Robins RK
J Med Chem; 1990 Jan; 33(1):121-8. PubMed ID: 2296010
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines related to formycin prepared via ring closure of a 1,2,4-triazine precursor.
Ramasamy K; Ugarkar BG; McKernan PA; Robins RK; Revankar GR
J Med Chem; 1986 Nov; 29(11):2231-5. PubMed ID: 3783585
[TBL] [Abstract][Full Text] [Related]
17. Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity.
Cristalli G; Vittori S; Eleuteri A; Grifantini M; Volpini R; Lupidi G; Capolongo L; Pesenti E
J Med Chem; 1991 Jul; 34(7):2226-30. PubMed ID: 2066996
[TBL] [Abstract][Full Text] [Related]
18. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase.
Balzarini J; Stet L; Matsuda A; Wiebe L; Knauss E; De Clercq E
Adv Exp Med Biol; 1998; 431():723-8. PubMed ID: 9598159
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 5-amino-1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine and certain related nucleosides as inhibitors of purine nucleoside phosphorylase.
Sanghvi YS; Hanna NB; Larson SB; Fujitaki JM; Willis RC; Smith RA; Robins RK; Revankar GR
J Med Chem; 1988 Feb; 31(2):330-5. PubMed ID: 3123692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
